Almac relaunches IVR/IWR platform targeting small and mid-sized firms
Almac has revamped its IVR/IWR system citing small and mid-sized pharmas with less to spend on trials as its target market.
Archives for March 22, 2012
GSK confirms £500m investment after UK introduces tax 'patent box'
GSK has made good on its promise to invest in the UK, confirming plans to spend £500m ($789m) on new manufacturing capacity in the country just a day after the Government introduced a tax ‘patent box.'
Drug shortage fixes can ready US for disasters; IOM
Experience handling the wave of drug shortages in the US can improve disaster response plans, the IOM wrote.
Explosive deal for healthcare logistics sector? UPS bids $7bn for TNT
Another deal impacting the Pharma logistics space this week with rumoured former World Courier suitor UPS agreeing to stump up €5.2bn ($6.8bn) for Dutch rival TNT Express NV.
AMRI to end operations at Hungary site by next Friday
AMRI is to end operations at its discovery and chemistry services facility in Hungary by the end of next week.
Big Pharma interest shows FSP model is “alive and well”
The FSP model is “alive and well” with inVentiv, INC Research, and others in the hunt for sizable deals with big pharma companies.
Health Canada working night and day to fix Sandoz shaped hole in supply chain
Health Canada officials are working “around the clock” to approve 23 new drug applications in one month to combat national meds shortages caused by troubles at Sandoz.
IPEC Americas wants input on FDA inactive ingredient database
IPEC Americas wants member input for US Food and Drug Administration (FDA) inactive ingredient database (IID) subcommittee.